Mathuram Santosham

Affiliations: 
Johns Hopkins University, Baltimore, MD 
Area:
Public Health
Google:
"Mathuram Santosham"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Cella E, Sutcliffe CG, Grant LR, et al. (2024) serotype 3 population structure in the era of conjugate vaccines, 2001-2018. Microbial Genomics. 10
Checkley W, Hossen S, McCollum ED, et al. (2022) Effectiveness of the 10-valent pneumococcal conjugate vaccine on pediatric pneumonia confirmed by ultrasound: a matched case-control study. Respiratory Research. 23: 198
Leach AJ, Wilson N, Arrowsmith B, et al. (2022) Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trials. The Lancet. Infectious Diseases
Skansberg A, Sauer M, Tan M, et al. (2020) Product review of the rotavirus vaccines ROTASIIL, ROTAVAC, and Rotavin-M1. Human Vaccines & Immunotherapeutics. 1-12
McCollum ED, Ahmed S, Roy AD, et al. (2020) Effectiveness of the 10-valent pneumococcal conjugate vaccine against radiographic pneumonia among children in rural Bangladesh: A case-control study. Vaccine
Holroyd TA, Wahl B, Gupta M, et al. (2020) Characterizing mothers and children at risk of being under-immunized in India: a latent class analysis approach. International Journal of Infectious Diseases : Ijid : Official Publication of the International Society For Infectious Diseases
Wahl B, Knoll MD, Shet A, et al. (2020) National, regional, and state-level pneumonia and severe pneumonia morbidity in children in India: modelled estimates for 2000 and 2015. The Lancet. Child & Adolescent Health. 4: 678-687
Ahmed S, Mvalo T, Akech S, et al. (2020) Protecting children in low-income and middle-income countries from COVID-19. Bmj Global Health. 5
Oguoma VM, Wilson N, Mulholland K, et al. (2020) 10-Valent pneumococcal non-typeable protein D conjugate vaccine (PHiD-CV10) versus 13-valent pneumococcal conjugate vaccine (PCV13) as a booster dose to broaden and strengthen protection from otitis media (PREVIX_BOOST) in Australian Aboriginal children: study protocol for a randomised controlled trial. Bmj Open. 10: e033511
Baqui AH, McCollum ED, Mahmud A, et al. (2020) Population-based incidence and serotype distribution of invasive pneumococcal disease prior to introduction of conjugate pneumococcal vaccine in Bangladesh. Plos One. 15: e0228799
See more...